St Phi Therapeutics, Inc was duly registered on 2017-12-12 as a Foreign Profit Corporation, with its principal office located at 1100 NE CAMPUS PKWY STE 200, STARTUP HALL BOX 354625, SEATTLE, WA, 98105-6605, UNITED STATES. The company falls under the classification of North American Industry Classification System (NAICS) code 7, which pertains to Professional, Scientific & Technical Services, THE MISSION OF ST PHI THERAPEUTICS IS TO DEVELOP INNOVATIVE DIAGNOSTIC REAGENTS, CELLULAR THERAPEUTICS TECHNOLOGIES AND ENGINEERED CELL PRODUCTS TO HELP CURE HUMAN DISEASES, INCLUDING CANCER, AUTOIMMUNE DISEASE, VIRUS-INFECTION DISEASES AND AGING. WE COULD DO BUSINESS ON SELLING THE DIAGNOSTIC REAGENTS, LICENSING THE TECHNOLOGIES OR COLLABORATE WITH HOSPITALS TO PRODUCE THE THERAPETIC CELL PRODUCTS IN THE NEAR FUTURE.. Steven Liu is the appointed agent of the company. Presently, the business record indicates an Terminated status.
ST PHI THERAPEUTICS, INC's dissolution date was Apr 03 2020 and it had been operational for a period of 2 years 3 months, and 22 days since it registered.
Name | Title | Address |
---|---|---|
LINGFENG (STEVEN) LIU | Governor | 811 1ST AVE STE 409 SEATTLE WA 98104-1418 |
XIAOBIN GUO | Governor | 811 1ST AVE STE 409 SEATTLE WA 98104-1418 |